Ahead of print

Original article

Histomorphological Changes in Experimental Autoimmune Uveitis of Varying Severity

Full Text links

Summary

Aim: to evaluate the histomorphology of the eyes of rabbits with experimental autoimmune uveitis (EAU) of varying severity.

Materials and Methods: The study was conducted on 30 Chinchilla rabbits with EAU, which were divided into two groups according to the severity of the disease. Histomorphological examination of the rabbit eyes was performed.

Results: In general, the inflammatory process can be characterized as a humoral-type hypersensitivity reaction. An inflammatory process was observed, predominantly affecting the inner ocular layers – mainly the choroid and retina. Inflammatory changes in the iris were sporadic, minimal, and primarily consisted of a few scattered lymphocyte-like cells. In the ciliary body, inflammation predominantly involved the ciliary processes. Damage to the retinal pigment epithelium was predominantly observed in the optical part. The involvement of the choroidal vasculature was evident, accompanied by stromal exudation. Retinal alterations predominantly involved the inner layers.
The bipolar and ganglion cell layers were essentially destroyed, while the photoreceptor layer was largely preserved. Destruction of the retinal pigment epithelium was associated with damage to Bruch’s membrane.

Conclusion: Overall, histomorphological alterations in EAU showed a time-dependent progression, peaking between Days 3 and 10, particularly in moderate and severe cases. Although inflammatory activity decreased from Day 14 onward, complete morphological recovery was not observed. Persistent intergroup differences indicate sustained, partially irreversible ocular tissue damage associated with disease severity.

References

  1. Biswas J, Annamalai R, Krishnaraj V. Biopsy pathology in uveitis. Middle East Afr J Ophthalmol. 2011;18(3):232-238.
  2. Hysa E, Cutolo CA, Gotelli E, et al. Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: an update. Eur J Clin Invest. 2021;51(12):e13572.
  3. London NJS, Rathinam SR, Cunningham ETJr. The epidemiology of uveitis in developing countries. Int Ophthalmol Clin. 2010;50(2):1-17.
  4. Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121(12):2387-2392.
  5. Durrani OM, Tehrani NN, Marr J.E, Moradi P, Stavrou P, Murray P.I. Degree, duration, and causes of visual loss in uveitis.Br J Ophthalmol. 2004;88(9):1159-1162.
  6. Bansal S, Barathi VA, Iwata D, Agrawal R. Experimental autoimmune uveitis and other animal models of uveitis: An update. Indian J Ophthalmol. 2015;63(3):211–218.
  7. Bora NS, Sohn JH, Kang SG, et al. Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J Immunol. 2004;172:7086-7094.
  8. Horai R, Silver PB, Agarwal RK, et al. Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a retina-specific T cell receptor. Int Immunol. 2010;22:21.
  9. Zernii EY, Baksheeva VE, Iomdina EN, et al. Rabbit Models of Ocular Diseases: New Relevance for Classical Approaches. CNS Neurol Disord Drug Targets. 2016;15(3):267-91.
  10. Brown SDM. Advances in mouse genetics for the study of human disease. Human Molecular Genetics. 2021;30(2):274-284.
  11. Babinet C. Transgenic mice: an irreplaceable tool for the study of mammalian development and biology. J Am Soc Nephrol. 2000;16:88-94.
  12. Pasechnikova NV, Zborovska OV, Nasinnyk IO, Velichko LM, Bohdanova OV, inventors; SI “The Filatov Institute of Eye Diseases and Tissue Therapy of NAMS of Ukraine”. Method of simultaneous modeling of autoimmune uveitis of various severity levels. Ukraine patent UA 112120. 2016 Dec 12.
  13. Smalyuh NV. Experimental justification of phonophoresis of fluorafur and its application in the treatment of endogenous uveitis [author’s abstract for the dissertation] Odessa; 1986.
  14. Kuryltsiv N, Zborovska O, Velychko L, Bohdanova A. T-Cells Response in Experimental Autoimmune Uveitis of Varying Severity. Ceska a slovenska oftalmologie. 2024;80:1-8.
  15. Fan N-W, Li Y, Mittal SK, et al. Characterization of Clinical and Immune Responses in an Experimental Chronic Autoimmune Uveitis Model. Am J Pathol. 2021 Mar;191(3):425-437.
  16. Kuryltsiv NB, Zborovska OV, Velychko LM, Khyrivskyi AL. Dynamics of theinflammatory biomarker neopterin level in experimental non-infectious autoimmune uveitis. Lviv Clinical Bulletin. 2022;3(39) - 4(40):33-39.
  17. Caspi RR. Understanding Autoimmune Uveitis through Animal Models. Invest Ophthalmol Vis Sci. 2011 Mar;52(3):1873-1879.
  18. Agarwal A, Agarwal RK, Silver PB, Caspi RR. Rodent models of experimental autoimmune uveitis. Int J Inflam. 2012;2012:1-18.
  19. McMenamin PG, Broekhuyse RM, Forrester JV. Ultrastructural pathology of experimental autoimmune uveitis: A review. Micron. 1993; 24(5):521-546.
  20. Dua HS. Ultrastructural pathology of experimental autoimmune uveitis. Eye (Lond). 1993;7:567-575.
  21. Côté MA, Rao NA. The role of histopathology in the diagnosis and management of intraocular inflammatory disease. Can J Ophthalmol. 1990;25(6):283-289.
  22. Lim LL, Suhler EB, Rosenbaum JT, Wilson DJ. The role of choroidal and retinal biopsies in the diagnosis and management of atypical presentations of uveitis. Trans Am Ophthalmol Soc. 2005;103:84-91.